Last reviewed · How we verify
NCT03341780
Standard Amblyopia Therapy in Adult Amblyopes
trial testing amblyopia therapy in Amblyopia in 9 participants. Completed in 24 October 2016.
24 October 2016
Quick facts
| Lead sponsor | Southern California College of Optometry at Marshall B. Ketchum University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 9 |
| Start date | 16 December 2014 |
| Primary completion | 24 October 2016 |
| Estimated completion | 24 October 2016 |
Drugs / interventions tested
- amblyopia therapy
Conditions studied
- Amblyopia — all drugs for Amblyopia →
Sponsor
Southern California College of Optometry at Marshall B. Ketchum University
Who can join
18 and older, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Amblyopia is characterized by a reduction in visual acuity, contrast sensitivity, and binocular visual functions. The two main causes of amblyopia are anisometropia and strabismus which alter the synaptic connections between neurons along the visual pathway. Current treatment for amblyopia has indicated that the younger the amblyope, the greater the effect of treatment. The purpose of this study is to determine if standard amblyopia treatment improved visual acuity in adult amblyopes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03341780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amblyopia
Currently open trials in the same condition.
- NCT07323953 — Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children · NA · recruiting
- NCT07281742 — Amblyopia Treatment for Children Aged 8 to 12 Years · NA · recruiting
- NCT07417046 — Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopi · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
- NCT06380517 — Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age · Phase 3 · recruiting
Other Southern California College of Optometry at Marshall B. Ketchum University trials
Trials by the same sponsor.
- NCT05801991 — Neurolens and Contact Lens Discomfort · NA · completed
- NCT06154200 — Eyelid Androgen Treatment in Dry Eye · Phase 2 · completed
- NCT03305484 — Soft Contacts Observation of Risk and Education (SCORE) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03341780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Southern California College of Optometry at Marshall B. Ketchum University
- Last refreshed: 17 November 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing